Stay Updated with the Latest Ortho Clinical Diagnostics Holdings plc OCDX News in Real Time
Find OCDX news now at Meyka AI. Stay informed with the latest Ortho Clinical Diagnostics Holdings plc stocks updates, including price news, market analysis, and expert insights.
Robinhood Stock Rises 4.63% to $95.77 as MSTR, COIN and CRCL Rally on Treasury Buyback
Robinhood stock closed at $95.77 on August 19, 2026, up 4.63% for the session. Strategy, Coinbase, and Circle all posted stronger gains the same day. The U.S. Treasury’s expanded bond buyback program eased yields and lifted risk appetite across crypto-linked equities. Bitcoin climbed above $68,000, extending gains into $71,600 territory by Thursday morning. Why Robinhood…
HMRC Sends 81,000 Crypto Tax Warning Letters as Enforcement Nearly Triples
HMRC sent 81,000 crypto tax warning letters in 2025-26, up from 27,714 in 2023-24. Penalties for non-compliance can reach 100% of unpaid tax. New powers arrive May 2027.
US Debt Rises $11.6 Trillion During Trump’s Two Terms, Outpacing Biden’s $8.4T
US debt has climbed $11.6 trillion across Donald Trump’s two terms combined, according to Treasury Department data released this week. That total spans both his 2017-2021 term and his current second term since January 2025. Biden’s single term added $8.4 trillion by comparison. Total US debt crossed $40 trillion for the first time on August…
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.
Lambie Demands Cap Scrapped as Veterans’ Health Funding Faces $5,000 Limit
Jacqui Lambie attacks federal government’s $5,000 allied health cap for veterans, warning it could cost lives. Policy takes effect July 2027. RSL Australia and advocacy groups oppose the measure.
Adani Shares Surge 34% in 2026 as Flagship Stock Eyes Nifty 50’s Top Gainer Crown
Adani shares have jumped 34% so far in 2026, making Adani Enterprises the top performer on the Nifty 50 Index. The flagship stock last held that spot at the end of 2022, right before the Hindenburg Research report hit in January 2023. This rally marks a full turnaround for Asia’s richest man, Gautam Adani, and…
DR Congo Ebola Outbreak Kills 2,325, Becomes Deadliest in Country’s History
DR Congo’s Ebola outbreak kills 2,325 people, becoming the deadliest in the country’s history. The Bundibugyo strain has no approved vaccine or treatment, and the UN warns the epidemic is killing one person every 30 minutes.